Overview of hemostasis and thrombosis; current status of antithrombotic therapies

Thrombosis Research

Volumn 117, Issue 1-2, 2005, Pages 15-17

  Horne, McDonald ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGATROBAN; ARGININE; FONDAPARINUX; HEPARIN; HIRUDIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ARTICLE; BIOCHEMISTRY; BLEEDING; BLOOD CLOTTING; BLOOD FLOW; BLOOD VESSEL; HEMOSTASIS; PHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; FIBRINOLYTIC AGENTS; HOMEOSTASIS; HUMANS; MODELS, CARDIOVASCULAR; PLATELET ACTIVATION; THROMBOSIS;

EID: 27744462382     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.05.007     Document Type: Article

References (3)

1. H.R. Roberts, D.M. Monroe, and M. Hoffman Molecular biology and biochemistry of the coagulation factors and pathways of hemostasis E. Beutler M.A. Lichtman B.S. Coller T.J. Kipps U. Seligsohn Williams Hematology 6th edition 2001 McGraw-Hill New York 1409 1434
2. R.E. Simmonds, and D.A. Lane Regulation of coagulation J. Loscalzo A.I. Schafer Thrombosis and Hemorrhage 2nd edition 1998 Williams and Wilkins Baltimore 45 76
3. Alving BM, guest editor. New Treatment Strategies for Thrombotic Disorders. Semin Hematol 2002;39(3).